MYD88 and diffuse large B-cell lymphoma: According to comprehensive genetic analysis, DLBCL cases harboring MYD88 and CD79B mutations are classified as the MCD type12, 13 and the cluster 5 type,14 a characteristic subgroup with poor prognosis.